These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44 related articles for article (PubMed ID: 1280034)
1. Puromycin is a potent and specific inhibitor of tyrosine kinase activity in HL-60 cells. Davidoff AN; Mendelow BV Anticancer Res; 1992; 12(5):1761-6. PubMed ID: 1280034 [TBL] [Abstract][Full Text] [Related]
2. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients. Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223 [TBL] [Abstract][Full Text] [Related]
3. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells. Kamps MP; Sefton BM Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525 [TBL] [Abstract][Full Text] [Related]
4. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527. Cobb BS; Parsons JT Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368 [TBL] [Abstract][Full Text] [Related]
5. Effects of tyrphostins on the activated c-src protein in NIH/3T3 cells. Agbotounou WK; Levitzki A; Jacquemin-Sablon A; Pierre J Mol Pharmacol; 1994 May; 45(5):922-31. PubMed ID: 7514714 [TBL] [Abstract][Full Text] [Related]
7. Disruption of cell-substrate adhesion activates the protein tyrosine kinase pp60(c-src). Maher PA Exp Cell Res; 2000 Nov; 260(2):189-98. PubMed ID: 11035913 [TBL] [Abstract][Full Text] [Related]
8. Effects of protein kinase C on delayed rectifier K+ channel regulation by tyrosine kinase in rat retinal pigment epithelial cells. Strauss O; Rosenthal R; Dey D; Beninde J; Wollmann G; Thieme H; Wiederholt M Invest Ophthalmol Vis Sci; 2002 May; 43(5):1645-54. PubMed ID: 11980886 [TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners. Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331 [TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of a cytoskeleton-associated, epidermal growth factor sensitive pp60c-src substrate. Maa MC; Wilson LK; Moyers JS; Vines RR; Parsons JT; Parsons SJ Oncogene; 1992 Dec; 7(12):2429-38. PubMed ID: 1281304 [TBL] [Abstract][Full Text] [Related]
12. Certain inhibitors of protein serine/threonine kinases also inhibit tyrosine phosphorylation of phospholipase C gamma 1 and other proteins and reveal distinct roles for tyrosine kinase(s) and protein kinase C in stimulated, rat basophilic RBL-2H3 cells. Yamada K; Jelsema CL; Beaven MA J Immunol; 1992 Aug; 149(3):1031-7. PubMed ID: 1378861 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells. Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927 [TBL] [Abstract][Full Text] [Related]
14. Biochemical characterization of tyrosine kinase and phosphotyrosine phosphatase activities of HL-60 leukemia cells. Frank DA; Sartorelli AC Cancer Res; 1988 Aug; 48(15):4299-306. PubMed ID: 2455595 [TBL] [Abstract][Full Text] [Related]
15. Protein tyrosine phosphorylation and p56lck modification in IL-2 or phorbol ester-activated human natural killer cells. Einspahr KJ; Abraham RT; Dick CJ; Leibson PJ J Immunol; 1990 Sep; 145(5):1490-7. PubMed ID: 1696599 [TBL] [Abstract][Full Text] [Related]
16. Protein synthesis inhibition is not a requisite for puromycin- and cycloheximide-induced c-myc mRNA superinduction. Davidoff AN; Mendelow BV Anticancer Res; 1994; 14(3A):1199-201. PubMed ID: 8074472 [TBL] [Abstract][Full Text] [Related]
17. Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases. Torres M; Hall FL; O'Neill K J Immunol; 1993 Feb; 150(4):1563-77. PubMed ID: 7679431 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells. Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364 [TBL] [Abstract][Full Text] [Related]
19. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain. Liu X; Brodeur SR; Gish G; Songyang Z; Cantley LC; Laudano AP; Pawson T Oncogene; 1993 May; 8(5):1119-26. PubMed ID: 7683128 [TBL] [Abstract][Full Text] [Related]